ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,675.29
1.08%
US Tech 100
19,073.60
-0.84%
다우존스 지수
41,964.63
0.92%
Bitcoin
85,223.25
-1.92%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. KalVista Pharmaceuticals Inc (KALV) 시세

KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals Inc (KALV)

NASDAQ
12.10
-0.27
(-2.18%)
마감 20 3월 5:00AM
15분 지연
12.10
0.00
( 0.00% )
시간외 단일가: 5:19PM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
12.10
매수가
9.63
매도가
13.75
거래량
37
0.00 일간 변동폭 0.00
7.30 52주 범위 15.50
market_cap
601.559M
전일 종가
12.10
개장가
-
최근 거래 시간
17
@
12.38
마지막 거래 시간
18:03:02
재정 규모
-
VWAP
-
평균 볼륨(3m)
418,176
발행 주식
49,715,636
배당수익률
-
주가수익률
-4.75
주당순이익(EPS)
-2.55
매출
-
순이익
-126.64M

KalVista Pharmaceuticals Inc 정보

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angio... KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.kalvista.com
본부
Dover, Delaware, USA
설립됨
-
KalVista Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker KALV. The last closing price for KalVista Pharmaceuticals was US$12.10. Over the last year, KalVista Pharmaceuticals shares have traded in a share price range of US$ 7.30 to US$ 15.50.

KalVista Pharmaceuticals currently has 49,715,636 shares in issue. The market capitalisation of KalVista Pharmaceuticals is US$601.56 million. KalVista Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.75.

KALV 최신 뉴스

추가 뉴스

Form 8-K - Current report
Edgar (US Regulatory)
18 3월 2025
KALV (-2.18%)

Form 8-K - Current report
Edgar (US Regulatory)
13 3월 2025
KALV (-2.18%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
13 3월 2025
KALV (-2.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
11 3월 2025
KALV (-2.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
26 2월 2025
KALV (-2.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
26 2월 2025
KALV (-2.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
26 2월 2025
KALV (-2.18%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.25-2.0242914979812.3512.7411.5143345912.35730684CS
41.3912.978524743210.7112.99.94463413711.4805314CS
123.4439.72286374138.6612.97.341817610.32514256CS
261.1210.200364298710.9812.97.342185510.32434517CS
520.10.8333333333331215.57.337884411.13792063CS
156-3.1-20.394736842115.217.064.1236062710.50743057CS
2605.6186.44067796616.49454.1232871015.49268895CS

KALV - Frequently Asked Questions (FAQ)

What is the current KalVista Pharmaceuticals share price?
The current share price of KalVista Pharmaceuticals is US$ 12.10
How many KalVista Pharmaceuticals shares are in issue?
KalVista Pharmaceuticals has 49,715,636 shares in issue
What is the market cap of KalVista Pharmaceuticals?
The market capitalisation of KalVista Pharmaceuticals is USD 601.56M
What is the 1 year trading range for KalVista Pharmaceuticals share price?
KalVista Pharmaceuticals has traded in the range of US$ 7.30 to US$ 15.50 during the past year
What is the PE ratio of KalVista Pharmaceuticals?
The price to earnings ratio of KalVista Pharmaceuticals is -4.75
What is the reporting currency for KalVista Pharmaceuticals?
KalVista Pharmaceuticals reports financial results in USD
What is the latest annual profit for KalVista Pharmaceuticals?
The latest annual profit of KalVista Pharmaceuticals is USD -126.64M
What is the registered address of KalVista Pharmaceuticals?
The registered address for KalVista Pharmaceuticals is 3500 S DUPONT HWY, DOVER, DELAWARE, 19901
What is the KalVista Pharmaceuticals website address?
The website address for KalVista Pharmaceuticals is www.kalvista.com
Which industry sector does KalVista Pharmaceuticals operate in?
KalVista Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
SAGSAG Holdings Ltd
US$ 1.20
(77.78%)
8.63M
OPTNOptiNose Inc
US$ 9.60
(60.00%)
161.1k
LEELee Enterprises Inc
US$ 11.99
(36.72%)
14
IMGCIMG Inc
US$ 0.6427
(33.90%)
5.54M
IDYAIDEAYA Biosciences Inc
US$ 23.99
(31.74%)
59
TRUETrueCar Inc
US$ 0.7234
(-58.43%)
1
CSQCalamos Strategic Total Return Fund
US$ 10.01
(-39.52%)
1
ZCARZoomcar Holdings Inc
US$ 0.2149
(-29.98%)
129.33k
AKBAAkebia Therapeutics Inc
US$ 2.09
(-26.41%)
149.07k
NEHCNew Era Helium Inc
US$ 2.00
(-20.32%)
24
AGMHAGM Group Holdings Inc
US$ 0.09
(25.00%)
38.34M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7.86
(-3.44%)
16.9M
BTOGBit Origin Ltd
US$ 0.3131
(18.20%)
10.8M
SAGSAG Holdings Ltd
US$ 1.19
(76.30%)
8.63M
IMGCIMG Inc
US$ 0.6428
(33.92%)
5.54M

KALV Discussion

게시물 보기
diversified holdings diversified holdings 1 주 전
Looks like it wants to eclipse the 52 week high. Lots of insiders loading up over the past month.
👍️0
Monksdream Monksdream 2 주 전
KALV under $13

👍️0
Monksdream Monksdream 9 월 전
KALV 10Q expected July 5
👍️0
Monksdream Monksdream 12 월 전
KALV over $10
👍️0
Monksdream Monksdream 1 년 전
KALV new 52=week high
👍️0
clydesur clydesur 1 년 전
INSIDER PURCHASE / SYNDICATE

KALV - 10% OWNER Venrock Healthcare P 86,048 $14.618
👍️0
Monksdream Monksdream 1 년 전
KALV new 52 week high
👍️0
Monksdream Monksdream 1 년 전
KALV new 52 week high
👍️0
Femto99 Femto99 4 년 전
I would not even buy the shares at $20.
👍️0
Femto99 Femto99 4 년 전
All in puts!
👍️0
Stock_Barber Stock_Barber 4 년 전
Boom!

Killed it with puts today!

👍️0
ClayTrader ClayTrader 4 년 전
* * $KALV Video Chart 02-09-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
Stock_Barber Stock_Barber 4 년 전
This company is a disaster...

👍️0
make it happen make it happen 4 년 전
The company is delinquent.
👍️0
make it happen make it happen 4 년 전
? lol

Profitability
Profit Margin 0.00%
Gross Profit (ttm) $-27.5M
EBITDA $-48.38M
Net Income Avi to Common (ttm) $-37.12M
Diluted EPS (ttm) -2.08

Book Value Per Share (mrq) $3.63

Going to keep diluting more and more
👍️0
make it happen make it happen 4 년 전
They are hemorrhaging money. Have pretty much zero revenue. They still have hundreds of millions to spend of your money until phase 3 and beyond.

Operating Margin (ttm) -905.50%

Management Effectiveness

Return on Assets (ttm) -32.60%
Return on Equity (ttm) -45.61%

Revenue  $5.4M
Revenue Per Share  $0.30

👍️0
TFMG TFMG 5 년 전


$KALV Kalvista Pharma Trend Break



Major Downtrend broken
Broken above 200ma
Volume increased
MACD reversed
RSi in bullish uptrend



👍️0
whytestocks whytestocks 6 년 전
News: $KALV KalVista Pharmaceuticals Appoints Daniel B. Soland to Board of Directors

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, announced today that Daniel Soland has been appointed to its Board of Directors effective immediately. Mr...

Find out more https://marketwirenews.com/news-releases/kalvista-pharmaceuticals-appoints-daniel-b-soland-to-board-of-directors-8035190.html
👍️0
whytestocks whytestocks 6 년 전
News: $KALV KalVista Pharmaceuticals to Present at Needham Healthcare Conference

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today announced that it will present at the Needham Healthcare Conference on Wednesday, April 10, 2019, a...

Read the whole news https://marketwirenews.com/news-releases/kalvista-pharmaceuticals-to-present-at-needham-healthcare-conference-7939130.html
👍️0
stocktrademan stocktrademan 6 년 전
KALV buy 28.87



normal chart







log chart






👍️0
whytestocks whytestocks 6 년 전
News: $KALV KalVista Pharmaceuticals Reports Fiscal Third Quarter Results

– Oral Hereditary Angioedema (HAE) Candidate KVD900 Phase 2 Trial Progressing – – Intravitreal Diabetic Macular Edema (DME) Candidate KVD001 Phase 2 Trial Completion Expected H2 2019 – – Oral Plasma Kallikrein Inhibitor Candidate KVD824 Dosi...

Read the whole news https://marketwirenews.com/news-releases/kalvista-pharmaceuticals-reports-fiscal-third-quarter-results-7846828.html
👍️0
countryrapper2000 countryrapper2000 7 년 전
Where is everyone?
👍️0
TheFinalCD TheFinalCD 7 년 전
$17.85 !!


KALV
👍️0
Lone Wolf Lone Wolf 7 년 전
Sniffer rocket ship today!! Wheeee.

KALV
👍️0
TheFinalCD TheFinalCD 7 년 전
$15.50 now ~ keep rollin



$KALV
👍️0
kondziu kondziu 8 년 전
http://m.nasdaq.com/article/sv-life-sciences-advisers-llc-buys-kalvista-pharmaceuticals-sells-raptor-pharmaceutical-cm744623
👍️0
Warchest Warchest 8 년 전
$8.25 now ~ keep rollin
👍️0
ming1234 ming1234 8 년 전
any positive news and volume will move this north
👍️0
Warchest Warchest 8 년 전
LIVE action starting !!!
👍️0
Warchest Warchest 8 년 전
watching close ~
👍️0
Toxic Avenger Toxic Avenger 8 년 전
The way this is dropping, there has to be a lawsuit over the sale of cash at 60% off.
Where are those ambulance chasing securities lawyers?
👍️0
MSparks6 MSparks6 8 년 전
So when will CBYL holders be issued KALV common stock?
👍️0
Toxic Avenger Toxic Avenger 8 년 전
CBYL is now KALV with a 1:14 reverse stock split.

Be very careful for the next few days as until all or most of the CBYL shares are converted to KALV, the only sellers will be private Kal Vista investors, those who bought after the symbol change and professionals. The price is likely to be high until existing CBYL retail holders can sell their shares. In addition, the existing CBYL shares will only represent 20% of the O/S. 80% will be held by the private investors in KVAL.
👍️0
Iam_in Iam_in 8 년 전
$6.00
👍️0
Iam_in Iam_in 8 년 전
New Ticker symbol now: KALV
👍️0
Iam_in Iam_in 8 년 전
Correction : $5.49 PM
👍️0
Iam_in Iam_in 8 년 전
WOW - look at this $0,89---> $4,60

New Ticker name now : KALV

look at NASDAQ - PM
👍️0
Toxic Avenger Toxic Avenger 8 년 전
Apparently the merger deal was approved by a huge margin.

Still don't get it.
👍️0
ClayTrader ClayTrader 8 년 전
* * $CBYL Video Chart 11-21-16 * *

Link to Video - click here to watch the technical chart video
👍️0
beginneer beginneer 8 년 전
Attempting to break 0.72. GL to holders
👍️0
beginneer beginneer 8 년 전
We'll see how this goes. Hopefully back to over a dollar.
👍️0
Toxic Avenger Toxic Avenger 8 년 전
CBYL continuing its upward momentum pre-market.
👍️0
ClayTrader ClayTrader 8 년 전
* * $CBYL Video Chart 11-18-16 * *

Link to Video - click here to watch the technical chart video
👍️0
beginneer beginneer 8 년 전
Oh okay. Im still up for it even if it is a merger. Good thing volume picked up today.
👍️0
Toxic Avenger Toxic Avenger 8 년 전
New buyer? They're not being bought, they're merging with another company and selling their cash at a steep discount.

Maybe the large shareholders decided it's better to take a smaller loss now by liquidating, than wait for a larger loss later and they're voting against the deal.

I can only hope!
👍️0
beginneer beginneer 8 년 전
Somethings fishy going on here. Why the sudden spike in volume? New buyer in sight?
👍️0
Toxic Avenger Toxic Avenger 8 년 전
Fun while it lasted.
👍️0
Toxic Avenger Toxic Avenger 8 년 전
Big bounce today. Anyone know why?
👍️0
Toxic Avenger Toxic Avenger 8 년 전
$700k / month for a company that has only a few execs and no business left???

No wonder they want to merge. If they liquidate, the execs all lose their gravy train.

Maybe that can be part of the class action suit.
👍️0
Toxic Avenger Toxic Avenger 8 년 전
Looks like an attempt to prevent the merger by some shareholders has failed. http://ih.advfn.com/p.php?pid=nmona&article=72839538&symbol=CBYL
👍️0

최근 히스토리

NASDAQ
KALV
KalVista Pharmaceuticals
LSE
AAEV
Albion Enterprise Vct
LSE
QH67
Morg.st.b.v 24
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지